Evaluation of nephrotoxicity and ototoxicity following amikacin administration once daily or every 48 hours in neonates-Reference-Cited by-同舟云学术

Evaluation of nephrotoxicity and ototoxicity following amikacin administration once daily or every 48 hours in neonates

Published:2022-10-28 Issue:43 Volume:101 Page:e31425
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Endo Aiju,Hanawa Kazumi,Nemoto Atsushi,Ishikawa Takahiro,Kazama Shizuka,Kagami Yu,Maebayashi Yuki,Katsumata Nobuyuki,Naito Atsushi,Kobayashi Yoshifumi,Kawano Yayoi,Hanawa Takehisa

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference26 articles.

1. Synergistic activity of aminoglycoside-beta-lactam combinations against Pseudomonas aeruginosa with an unusual aminoglycoside antibiogram.;Clark;Med Microbiol Immunol,1990

2. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.;Giamarellou;Am J Med,1986

3. Aminoglycosides: a practical review.;Gonzalez;Am Fam Phys,1998

4. A pilot study on the use of amikacin in neonates: who should be monitored for ototoxicity?;Engler;South Afr J Infect Dis,2015

5. Cost considerations in therapeutic drug monitoring of aminoglycosides.;Bertino;Clin Pharmacokinet,1994

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Documento nacional de consenso de monitorización terapéutica de antibióticos y antifúngicos en el paciente pediátrico y neonatal de la Sociedad Española de Farmacia Hospitalaria (SEFH) y la Sociedad Española de Infectología Pediátrica (SEIP);Anales de Pediatría;2024-09

2. [Translated article] Therapeutic Drug Monitoring of antibiotic and antifungical drugs in paediatric and newborn patients. Consensus Guidelines of the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Paediatric Infectious Diseases (SEIP);Farmacia Hospitalaria;2024-09

3. Documento nacional de consenso de monitorización terapéutica de antibióticos y antifúngicos en el paciente pediátrico y neonatal de la Sociedad Española de Farmacia Hospitalaria (SEFH) y la Sociedad Española de Infectología Pediátrica (SEIP);Farmacia Hospitalaria;2024-09

4. Anti-biofilm activities and antibiotic synergy of naturally occurring compounds against drug-resistant rapidly growing mycobacteria;Microbiology Spectrum;2024-08-06

5. Incidence of Antimicrobial-Associated Acute Kidney Injury in Children: A Structured Review;Pediatric Drugs;2023-12-13